Elan/Dura Shareholder Lawsuit Gets Supreme Court Hearing Jan. 12
This article was originally published in The Pink Sheet Daily
Executive Summary
At issue is whether shareholders in a securities lawsuit must demonstrate “loss causation” by proving a causal link between the alleged fraud and a decline in stock price. The lawsuit stems from statements made by Dura about Ceclor CD sales and development of the Spiros albuterol device. Elan acquired Dura in 2000.